Inovio Pharmaceuticals, Inc.

$1.66

-0.01 (-0.30%)

Volume:

987 ($1.64K)

#2487 Volume #3738 Dollar Volume

Market Capitalization:

$114.69M

#4040 Market Cap

Inovio Pharmaceuticals Price Chart

Inovio Pharmaceuticals Volume Chart

Inovio Pharmaceuticals Market Segments

Premarket

+0.00(+0.00%)

Open	$1.66
Close	$1.66
Low	$1.66
Low Change	0.00 (0.00%)
High	$1.66
High Change	+0.00 (+0.00%)
Range	$0.00
Volume	987
Dollar Volume	$1.64K

After Hours Yesterday

+0.01(+0.60%)

Open	$1.67
Close	$1.68
Low	$1.67
Low Change	0.00 (0.00%)
High	$1.68
High Change	+0.01 (+0.60%)
Range	$0.01
Volume	220
Dollar Volume	$369.60

Regular Trading Hours Yesterday

+0.01(+0.30%)

Open	$1.66
Close	$1.67
Low	$1.63
Low Change	-0.04 (-2.11%)
High	$1.67
High Change	+0.01 (+0.60%)
Range	$0.05
Volume	474.506K
Dollar Volume	$790.05K

Premarket Yesterday

+0.01(+0.61%)

Open	$1.63
Close	$1.64
Low	$1.63
Low Change	0.00 (0.00%)
High	$1.65
High Change	+0.02 (+1.23%)
Range	$0.02
Volume	1.679K
Dollar Volume	$2.75K

Inovio Pharmaceuticals Moving Averages

5 Day Moving Average (SMA5)	$1.67
10 Day Moving Average (SMA10)	$1.70
20 Day Moving Average (SMA20)	$1.74
50 Day Moving Average (SMA50)	$1.66
100 Day Moving Average (SMA100)	$1.88
200 Day Moving Average (SMA200)	$1.95

Inovio Pharmaceuticals Statistics

Average Volume (30 Days)	889.62K
P/E Ratio (Current)	-1.37
EPS (Current)	-$1.23
Dividend Yield	0.00%
Free Cash Flow	-$88.92M
Cash Ratio	1.01
Current Ratio	1.40
Quick Ratio	1.40
Debt to Equity	0.00
Enterprise Value	$71.64M
EV to EBITDA	-0.84
EV to Sales	1096.38
Price to Book	4.81
Price to Cash Flow	—
Price to Free Cash Flow	—
Price to Sales	1773.94
Return on Assets	-1.14%
Return on Equity	-3.53%

Inovio Pharmaceuticals Stock Splits

There have been 2 stock splits for Inovio Pharmaceuticals (INO). The last reverse stock split occured on January 25, 2024 and reduced the outstanding shares at a ratio of 12:1.

Date	Type	Ratio
Jan 25, 2024	Reverse	12:1
Jun 9, 2014	Reverse	4:1

Inovio Pharmaceuticals Dividends

There have been no dividends for Inovio Pharmaceuticals (INO).